- Home
- ACDC vs ANIP Comparison
ACDC vs ANIP Comparison
Compare ACDC & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACDC
- ANIP
- Stock Information
- Founded
- ACDC 2014
- ANIP 2001
- Country
- ACDC United States
- ANIP United States
- Employees
- ACDC N/A
- ANIP N/A
- Industry
- ACDC Oilfield Services/Equipment
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- ACDC Energy
- ANIP Health Care
- Exchange
- ACDC Nasdaq
- ANIP Nasdaq
- Market Cap
- ACDC 1.1B
- ANIP 1.2B
- IPO Year
- ACDC 2022
- ANIP N/A
- Fundamental
- Price
- ACDC $7.97
- ANIP $68.02
- Analyst Decision
- ACDC Hold
- ANIP Strong Buy
- Analyst Count
- ACDC 5
- ANIP 8
- Target Price
- ACDC $7.60
- ANIP $79.75
- AVG Volume (30 Days)
- ACDC 497.2K
- ANIP 361.8K
- Earning Date
- ACDC 03-06-2025
- ANIP 05-09-2025
- Dividend Yield
- ACDC N/A
- ANIP N/A
- EPS Growth
- ACDC N/A
- ANIP N/A
- EPS
- ACDC N/A
- ANIP N/A
- Revenue
- ACDC $2,190,900,000.00
- ANIP $614,376,000.00
- Revenue This Year
- ACDC N/A
- ANIP $27.62
- Revenue Next Year
- ACDC $12.88
- ANIP $7.71
- P/E Ratio
- ACDC N/A
- ANIP N/A
- Revenue Growth
- ACDC N/A
- ANIP 26.20
- 52 Week Low
- ACDC $5.16
- ANIP $52.50
- 52 Week High
- ACDC $9.75
- ANIP $70.00
- Technical
- Relative Strength Index (RSI)
- ACDC 49.73
- ANIP 66.14
- Support Level
- ACDC $6.90
- ANIP $65.28
- Resistance Level
- ACDC $8.29
- ANIP $69.33
- Average True Range (ATR)
- ACDC 0.40
- ANIP 2.32
- MACD
- ACDC 0.03
- ANIP 0.29
- Stochastic Oscillator
- ACDC 45.13
- ANIP 83.54
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: stimulation services, manufacturing, and proppant production. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.